Sponsor or institution

Clinical trials and research at Hubei Cancer Hospital

• 12Clinical trials
• 1Country

Newest trials

All recruiting trials (12)

• Gut microbiome differences in people on abemaciclib who do or don't get diarrhea

  This project will compare gut bacteria in people with HR-positive breast cancer who are taking abemaciclib to see if differences are linked to developing diarrhea.

  Recruiting Hubei Cancer Hospital · Wuhan, Hubei · NCT07264998

• Gut bacteria and diarrhea in breast cancer patients on pyrotinib

  This study will see if gut bacteria differ between breast cancer patients on pyrotinib who develop diarrhea and those who don’t, to understand why this side effect happens.

  Recruiting Hubei Cancer Hospital · Wuhan, Hubei · NCT07264985

• Monitoring blood markers during DIEP flap breast reconstruction

  We will see if measuring inflammation and oxidative stress markers in blood before and during the first 72 hours after DIEP flap reconstruction helps map recovery patterns for women having immediate breast reconstruction after mastectomy.

  Recruiting Hubei Cancer Hospital · Wuhan, Hubei · NCT07263347

• Minimal-invasive DNA test on nipple fluid to tell benign from malignant nipple discharge

  This study tests whether DNA analysis of nipple fluid can help tell benign from malignant causes of pathologic nipple discharge in adults undergoing diagnostic breast surgery.

  Recruiting Hubei Cancer Hospital · Wuhan, Hubei · NCT07250204

• Comparing surgical methods for treating granulomatous mastitis

  This study is testing whether traditional surgery or breast-conserving plastic surgery is better for people with granulomatous mastitis in terms of recurrence, side effects, appearance, and patient satisfaction.

  Recruiting Hubei Cancer Hospital · Wuhan, Hubei · NCT06712524

• Combining SBRT, chemotherapy, and AK112 for treating luminal-type breast cancer

  This study is testing whether combining a type of radiation therapy, chemotherapy, and a new immunotherapy can help people with luminal-type breast cancer respond better to treatment.

  Recruiting Phase 2 Hubei Cancer Hospital · Wuhan, Hubei · NCT06402435

• Combination of SBRT, chemotherapy, and AK104 for treating triple-negative breast cancer

  This study is testing a new treatment that combines radiation, chemotherapy, and an immune therapy to see if it helps people with triple-negative breast cancer respond better than standard treatments.

  Recruiting Phase 2 Hubei Cancer Hospital · Wuhan, Hubei · NCT06401005

• Comparing weekly and every 3 weeks ondansetron for preventing chemotherapy-induced nausea and vomiting

  This study is testing whether giving ondansetron weekly or every three weeks can better help cancer patients avoid nausea and vomiting from chemotherapy.

  Recruiting Hubei Cancer Hospital · Wuhan, Hubei · NCT06080880

• Evaluating the benefits of continued ovarian function suppression for breast cancer after 5 years

  This study is testing if continuing ovarian function suppression for premenopausal women with early hormone receptor positive breast cancer after 5 years helps them stay healthier compared to those who stop the treatment.

  Recruiting Hubei Cancer Hospital · Wuhan, Hubei · NCT06050109

• Radiotherapy approach for advanced lung cancer patients responding to immunotherapy and chemotherapy

  This study is testing if skipping a certain part of radiation treatment can help advanced lung cancer patients who have responded to immunotherapy and chemotherapy avoid lung problems while still keeping their tumors under control.

  Recruiting Hubei Cancer Hospital · Wuhan, Hubei · NCT06037733

• Single-drug chemotherapy combined with immunotherapy for elderly patients with metastatic lung cancer

  This study is testing if combining a single-drug chemotherapy with immunotherapy can help older patients with advanced lung cancer live longer and feel better compared to just using traditional chemotherapy.

  Recruiting Phase 2 Hubei Cancer Hospital · Wuhan, Hubei · NCT06032052

• Omitting radiation for advanced lung cancer patients who responded to treatment

  This study is testing whether skipping radiation for patients with advanced lung cancer who have responded well to initial treatment can help reduce side effects while still keeping the cancer under control.

  Recruiting Hubei Cancer Hospital · Wuhan, Hubei · NCT06020430

Quick answers

How many clinical trials run by Hubei Cancer Hospital are recruiting right now?

12, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →